OPT-101

N/A

Report date: 2026/04/10 20:01:49
NME

Base Information

Drug NameOPT-101
Drug Alias NameOPT-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-CD40
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsDiabetes Mellitus, Type 1SepsisPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOp-T LLC
China Registration ClassN/A

Develop Information

Active CompaniesOp-T LLC
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1SepsisPneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A